Prion protein can trigger spongiform encephalopathy and neurodegeneration

December 08, 2013

Transmissible spongiform encephalopathy or prion disease is triggered by the conversion from cellular prion protein to pathogenic prion protein. Notably, C-transmembrane form of prion protein and cytosolic prion protein can result in neurodegenerative diseases in cases of error location,aggregation tendency, failure of signal peptides, body stress or incomplete removal of topologic prion protein. Zhiqi Song and coworkers from China Agricultural University, China introduce two types of disease-associated prion proteins, the cytosolic form and the transmembrane form, during biosynthesis through the endoplasmic reticulum quality-control system, and propose an effective model and testing method for cytosolic forms of prion protein. Their studies, published in the Neural Regeneration Research (Vol. 8, No. 30, 2013), addressing the molecular mechanisms show that the pathogenic factor for prion disease is not limited to the prion protein, but also includes the complex intracellular environment, error location or incomplete removal of topologic prion protein.
Article: " Metabolism of minor isoforms of prion proteins: cytosolic prion protein and transmembrane prion protein," by Zhiqi Song, Deming Zhao, Lifeng Yang (State Key Laboratory for Agrobiotechnology, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China)

Song ZQ, Zhao DM, Yang LF. Metabolism of minor isoforms of prion proteins: cytosolic prion protein and transmembrane prion protein. Neural Regen Res. 2013;8(30):2868-2878.


Meng Zhao
Neural Regeneration Research

Full text:

Neural Regeneration Research

Related Prion Protein Articles from Brightsurf:

Naturally occurring antibodies against prion proteins found in humans
Antibodies targeting the normal PrP version of the prion protein have been found in humans selected at random with no history of any associated transmissible spongiform encephalopathies.

Researchers find new potential treatment for prion diseases
A new study in Nucleic Acids Research suggests a possible effective treatment strategy for patients suffering from prion disease.

Unraveling one of prion disease's deadly secrets
In a new paper in Nature Structural and Molecular Biology by Tricia Serio, dean of the College of Natural Sciences and professor of biochemistry and molecular biology at UMass Amherst, and others, report an unanticipated role for prion nucleation seeds that enhances their ability to appear and resist curing.

How does the prion protein clump? DNA-modulated liquid droplets may explain
Researchers at the Federal University of Rio de Janeiro (UFRJ), in Brazil, have found that the prion protein (PrP) suffers liquid-liquid phase separation, and that this mechanism is finely controlled by some DNA sequences.

Analyzing a protein from the cerebrospinal fluid will help diagnose patients with prion diseases
Recently, a study published in the Journal of Neurology, Neurosurgery & Psychiatry demonstrates that very high levels of neurogranin in the cerebrospinal fluid can be detected in human patients that suffer from prion diseases.

New skin test detects prion infection before symptoms appear
Prions can infect both humans and animals, causing Creutzfeldt-Jakob disease (CJD) in humans, mad cow disease in cattle, and chronic wasting disease in elk and deer.

BU researchers define possible molecular pathway for neurodegeneration in prion diseases
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Cross-species prion adaptation depends on prion replication environment
A hamster prion that replicated under conditions of low RNA levels in mouse brain material resulted in altered disease features when readapted and transmitted back to hamsters, according to new research presented in PLOS Pathogens by Elizaveta Katorcha of the University of Maryland School of Medicine, Baltimore, and colleagues.

Microglia are key defenders against prion diseases
Prion diseases are slow degenerative brain diseases that occur in people and various other mammals.

NIH scientists and collaborators find prion protein in skin of CJD patients
NIAID scientists and collaborators at Case Western Reserve University School of Medicine have detected abnormal prion protein in the skin of several people who died from Creutzfeldt-Jakob disease (CJD).

Read More: Prion Protein News and Prion Protein Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to